Cargando…
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
BACKGROUND: Pancreatic ductal adenocarcinoma is a lethal disease with a 5-year survival rate of 4% and typically presents in an advanced stage. In this setting, prognostic markers identifying the more agrressive tumors could aid in managment decisions. Insulin-like growth factor 2 mRNA binding prote...
Autores principales: | Schaeffer, David F, Owen, Daniel R, Lim, Howard J, Buczkowski, Andrew K, Chung, Stephen W, Scudamore, Charles H, Huntsman, David G, Ng, Sylvia SW, Owen, David A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837867/ https://www.ncbi.nlm.nih.gov/pubmed/20178612 http://dx.doi.org/10.1186/1471-2407-10-59 |
Ejemplares similares
-
IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
por: Huang, Wei, et al.
Publicado: (2023) -
Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023) -
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
por: Dahlem, Charlotte, et al.
Publicado: (2019) -
Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020) -
UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma
por: Fu, Wen, et al.
Publicado: (2023)